Zaychenko G. V., Gorchakova N. A., Sinitsina O. S., Zaychenko V. S., Ravshanov T. B.


About the author:

Zaychenko G. V., Gorchakova N. A., Sinitsina O. S., Zaychenko V. S., Ravshanov T. B.



Type of article:

Scentific article


Humans are exposed to cancerogens and is through the consumption of cruciferous vegetables that the people are able to neutralize the cancer causing agents. From the cruciferous vegetables the glucobrassicinin has been obtained and later indole-3-carbinol was produced from the hydrolysis of glucobrassin. Indole-3-carbinol has low toxicity. Indole-3-carbinol influences on the different phases of cycle in the tumor cells. Indole-3-carbinol affects several signal cascades. It inhibits different protein kinases, stimulates the production of specific inhibitors for cell division. These effects lead to the termination of cell division and interruption in the G1 phase and therefore to a halt in the dublication of chromatidis and subsequent mitosis. Indole-3-carbinol inhibits “nuclear factor cappa B” and different dependent genes. It regulates p53 gene and reduces the mitochondrial membrane potential leading to the apoptosis of cancer cells. Indole-3-carbinole influences on the prooxydative-antioxydative homeostasis, angiogenic factors-vascular endothelial growth factor, interleukin-6, matrix metalloproteinase. It reduces reactive oxygen species and increases the activity of gluthatione-S-transferase and superoxidedismutase as well as other enzymes that control oxidative status of the cells. Indole-3-carbinol influences estrogen homeostasis. Estradiol is the dominant and most effective estrogen in the human body. It is broken down into two metabolites: on the one hand to the less potent and less toxic-2-hydroxyestrone and on the other to the potent and toxic metabolite-16-alphahydroxyestrone. Indole-3-carbinol reduces conversion of estradiol into the dangerous 16-alpha-hydroxyestrone, which is regarded as tumor promoted. Indole-3-carbinol acts as direct noncompetitive inhibitor of elastase enzymatic activity: high elastase activity has been associated with late stage of breast cancer. Indole-3-carbinol triggers an elastase-dependent antiproliferate response in the10 AT-Her2 response of breast cancercell population by promoting nucleostemin to interact with and sequester the murine double mutant 2 protein into the nucleolus. It was shown the antiproliferative and anti-inflammatory properties of indole-3-carbinol. The anti-inflammatory effect was proved in the experiments with lipopolysaccharide. In the processes indole-3-carbinol inhibits the NF-kB activity as well as pro-inflammatory cytokines such as the TNF-alpha, IL-1-beta and IL-6. It was shown the effectivity of indole-3-carbinol in the cancer of hepar, lungs, prostata, in the papillomatosis of uterus, vagina, respiratory tracts. It was proved by experiments the possibility of indole-3-carbinol use in the ischemic shock, colitis. It was given the experimental and clinical data that are the basis for indole-3-carbinol use for wide spectrum of diseases treatment.


indole-3-carbinol, mechanism of antineoplastic action, anti-inflammatory, antioxidant, antithrombotic activities


  1. Karikas GA. Chemoprevention molecular and biochemical mechanisms involved in cancer control and management. Health science journal. 2011;5(2):149-56.
  2. Terry P, Wolk A, Persson I, Magnusson C. Brassica vegetables and breast cancer risk. Jama. 2001;285(23):2975-7.
  3. Halkier BA, Gershenzon J. Biology and biochemistry of glucosinolates. Annu. Rev. Plant Biol. 2006;57:303-33.
  4. Agerbrick N, De Vos M, Kim JH, Jander G. Indole glucosinolate breakdown and its biological effects. Phytochemistry. 2009;8:101-20.
  5. Fujioka N, Fritz V, Upadhyaya P, Kassie F, Hecht SS. Research on cruciferous vegetables, indole-3-carbinol, and cancer prevention: A tribute to Lee W. Wattenberg. Molecular nutrition & food research. 2016;60(6):1228-38.
  6. Brandi G, Paiardini M, Cervasi B, Fiorucci C, Filippone P, De Marco C, et al. A new indole-3-carbinol tetrameric derivative inhibits cyclindependent kinase 6 expression, and induces G1 cell cycle arrest in both estrogen-dependent and estrogen-independent breast cancer cell lines. Cancer research. 2003;63(14):4028-36.
  7. Higdon JV, Delage B, Williams DE, Dashwood RH. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacological Research. 2007;55(3):224-36.
  8. Katz E, Nisani S, Chamovitz D. Indole-3-carbinol: a plant hormone combatting cancer. F1000Research. 2018;7:689-96.
  9. Wang X, He H, Lu Y, Ren W, Teng KY, Chiang CL, et al. Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2015;1853(1):244-53.
  10. Firestone GL, Bjeldanes LF. Indole-3-carbinol and 3-3′-diindolylmethane antiproliferative signaling pathways control cell-cycle gene transcription in human breast cancer cells by regulating promoter–Sp1 transcription factor interactions. The Journal of nutrition. 2003;133(7):2448-55.
  11. Rahman KM, Aranha OP, Sarkar FH. Indole-3-carbinol (I3C) induces apoptosis in tumorigenic but not in nontumorigenic breast epithelial cells. Nutrition and cancer. 2003;45(1):101-12.
  12. Kravchenko LV, Gladkikh OL, Avrenteva LI, Tutelyan VA. Issledovanie antioksidantnykh svoystv indol-3-karbinola in vitro i in vivo. Voprosy biologicheskoy, meditsinskoy i farmatsevticheskoy khimii. 2008;6(4):18-23. [in Russiаn].
  13. Perez-Chacon GM, de Los Rios C, Zapata JM. Indole-3-carbinol induces cMYC and IAP-family down modulation and promotes apoptosis of Epstein–Barr virus (EBV)-positive but not of EBV-negative Burkitt’s lymphoma cell lines. Pharmacological research. 2014;89:46-56.
  14. Safa M, Jafari L, Alikarami F, Manafi Shabestari R, Kazemi A. Indole-3-carbinol induces apoptosis of chronic myelogenous leukemia cells through suppression of STAT5 and Akt signaling pathways. Tumour Biol. 2017;39(6). DOI: 1010428317705768
  15. Meng Q, Yuan F, Goldberg ID, Rosen EM, Auborn K, Fan S. Indole-3-carbinol is a negative regulator of estrogen receptor-α signaling in human tumor cells. The Journal of nutrition. 2000;130(12):2927-31.
  16. Aggarwal BB, Ichikawa H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell cycle. 2005;4(9):1201-15.
  17. Cohen T, Frydman-Marom A, Rechter M, Gazit E. Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivatives. Biochemistry. 2006;45(15):4727-35.
  18. Phuah NH, Nagoor NH. Regulation of microRNAs by natural agents: new strategies in cancer therapies. BioMed research international. 2014;2014:1-17.
  19. Clemons M, Goss P. Estrogen and the risk of breast cancer. England Journal of Medicine. 2001;344(4):276-85.
  20. Benninghoff AD, Williams DE. The role of estrogen receptor β in transplacental cancer prevention by indole-3-carbinol. Cancer Prevention Research. 2013;26:339-48.
  21. Konovalova VN. Rak molochnoy zhelezy i metabolizm estrogenov: vzglyad iznutri. Problemy reproduktsii. 2007;5:15-20. [in Russiаn].
  22. Kiselev VI, Lyashenko AA. Indinol – regulyator proliferativnykh protsessov v organakh reproduktivnoy sistemy. Monografiya. M.: 2005. 48 s. [in Russiаn].
  23. Nakamura Y, Yogosawa S, Izutani Y, Watanabe H, Otsuji E, Sakai T. A combination of indole-3-carbinol and genistein synergistically induces apoptosis in human colon cancer HT-29 cells by inhibiting. Akt phosphorylation and progression of autophagy. 2009;8(1):100-2.
  24. Chernichenko II, Kulakova YuA. Alternativnaya terapiya dobrokachestvennoy patologii molochnykh zhelez u zhenshchin reproduktivnogo i peri-i postmenopauzalnogo vozrastov. V: Sukhikh GT., redaktor. Materialy Kh Yubileynogo mezhdunarodnogo kongressa po reproduktivnoy meditsine; 2016 Yanv 19-22; Moskva: 2016. s. 137-9. [in Russiаn].
  25. Banerjee S, Kong D, Wang Z, Bao B, Hillman GG, Sarkar FH. Attenuation of multi-targeted proliferation-linked signaling by 3, 3′-diindolylmethane (DIM): from bench to clinic. Mutation Research. 2011;728(1):47-66.
  26. Ahmad A, Sakr W, Wahidur Rahman KM. Anticancer properties of indole compounds: mechanism of apoptosis induction and role in chemotherapy. Current drug targets. 2010;11(6):652-66.
  27. Marconett CN, Sundar SN, Tseng M, Tin AS, Tran KQ, Mahuron KM, et al. Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G 1 cell cycle arrest of human breast cancer cells. Carcinogenesis. 2011;32(9):1315-23.
  28. Aronchik I, Bjeldanes LF, Firestone GL. Direct inhibition of elastase activity by indole-3-carbinol triggers a CD40-TRAF regulatory cascade that disrupts NF-κB transcriptional activity in human breast cancer cells. Cancer research. 2010;70(12):4961-71.
  29. Aronchik I, Chen T, Durkin KA, Horwitz MS, Preobrazhenskaya MN, Bjeldanes LF, et al. Target protein interactions of indole-3-carbinol and the highly potent derivative 1-benzyl-I3C with the C-terminal domain of human elastase uncouples cell cycle arrest from apoptotic signaling. Molecular carcinogenesis. 2012;51(11):881-94.
  30. Tin AS, Park AH, Sundar ShN, Firestone GL. Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol antiproliferative responsiveness in human breast cancer cells.BMC biology. 2014;12(1):72-91.
  31. Kravchenko LV, Tutelyan VA, Trusov NV, Guseva G.V, Aksenov IV. Vliyanie polinenasyshchennykh zhirnykh kislot w-3 na induktsiyu indol-3karbinolom aktivnosti i ekspressii genov CYP1A1 i CYP1A2 v pecheni krys. Byulleten eksperimentalnoy biologii i meditsiny. 2013;156(9):302-6. [in Russiаn].
  32. Abdelmageed MM, El-Naga RN, El-Demerdash E, Elmazar MM. Indole-3-carbinol enhances sorafenib cytotoxicity in hepatocellular carcinoma cells: A mechanistic study. Scientific reports. 2016;6(32733):1-12.
  33. Qian X, Melkamu T, Upadhynaya P, Kassie F. Indole-3-carbinol inhibited tobacco smoke carcinogen-induced lung adenocarcinoma in A/J mice when administered during the post-initiation or progression phase of lung tumorogenesis. Cancer letters. 2011;311(1):57-65.
  34. Kadesnikova YuA, Tikhonovskaya OA, Petrov IA, Okorokov AO, Logvinov SV. Vliyanie indol-tri-karbinola na reproduktivnoe zdorove zhenshchin s funktsionalnymi kistami yaichnikov. Sibirskiy meditsinskiy zhurnal (Tomsk). 2010;25(4-2):123-5. [in Russiаn].
  35. Gerfanova YeV, Aleshikova OI, Ashrafyan LA. Preparaty indol-3-karbinola v sostave kombinirovannoy terapii raka yaichnikov, kak put k povysheniyu ee effektivnosti. Research’s Practical Medicine Journal. Onkologiya reproduktivnykh organov. 2017;2:40. [in Russiаn].
  36. Molochkov VA, Molochkova YuV. Indinol Forte i Egallokhit v terapii ostrokonechnykh i gigantskikh kondilom. Almanakh klinicheskoy meditsiny. 2014;34:100-3. [in Russiаn].
  37. Kiselev VI, Muyzhnyak LYe. Rol metabolitov estrogenov v kantserogeneze reproduktivnykh. Akusherstvo i ginekologiya. 2006;3:55-62. [in Russiаn].
  38. Soldatskiy YuL, Onufrieva YeK, Steklov AM, Gasparyan SF, Strygina YuV. Rezultaty adyuvantnoy terapii indol-3-karbinolom yuvenilnogo retsidiviruyushchego respiratornogo papillomatoza. Vestnik otorinolaringologii. 2011;5:47-9. [in Russiаn].
  39. Rosen CA, Bryson PC. Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results. Journal of Voice. 2004;18(2):248-53.
  40. Golyanovskiy OV, Roshchina GF. Effektivnost farmakoterapevticheskogo deystviya indol-3-karbinola v sostave preparata Kvinol. Zdorove zhenshchiny. 2014;4:148-54. [in Russiаn].
  41. Arutyunyan AF, Gaydukov SN. Novye aspekty patogeneticheski obosnovannoy terapii adenomioza v sochetanii s miomoy matki. Journal of Siberian Medical Sciences. 2015;35(6):26-9. [in Russiаn].
  42. Sazonova YeO, Vysotskiy MM, Garaeva LR. Effektivnost indol-3-karbinola v lechenii fibrozno-kistoznoy mastopatii u patsientok posle laparoskopicheskoy gisterektomii. Endoskopicheskaya khirurgiya. 2011;7(4):25-8. [in Russiаn].
  43. Wang SQ, Cheng LS, Liu Y, Wang JY, Jiang W. Indole-3-Carbinol (I3C) and its Major Derivatives: Their Pharmacokinetics and Important Roles in Hepatic Protection. Curr Drug Metab. 2016;17(4):401-19.
  44. Ampofo E, Lachnitt N, Rudzitis-Auth J, Schmitt BM, Menger MD, Laschke MW. Indole-3-carbinol is a potent inhibitor of ischemia–reperfusion– induced inflammation. Journal of Surgical Research. 2017;215:34-46.
  45. El-Naga RN, Ahmed HI, Al Haleem ENA. Effects of indole-3-carbinol on clonidine-induced neurotoxicity in rats: Impact on oxidative stress, inflammation, apoptosis and monoamine level. Neurotoxicology. 2014;44:48-57.
  46. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochemical pharmacology. 2006;71(10):1397-421.
  47. De Santi M, Galluzzi L, Duranti A, Magnani M, Brandi G. The Indole-3-carbinol cyclic tetrameric derivative CTet synergizes with cisplatin and doxorubicin in triple-negative breast cancer cell lines. Anticancer research. 2013;33(5):1867-72.
  48. El-Naga RN, Mahran YF. Indole-3-carbinol protects against cisplatin-induced acute nephrotoxicity: role of calcitonin gene-related peptide and insulin-like growth factor-1. Scientific reports. 2016;6:29857.
  49. Choi Y, Kim Y, Park S, Lee KW, Park T. Indole-3-carbinol prevents diet-induced obesity through modulation of multiple genes related to adipogenesis, thermogenesis or inflammation in the visceral adipose tissue of mice. The Journal of nutritional biochemistry. 2012;23(12):1732-9.
  50. Kundu A, Quirit JG, Khouri MG, Firestone GL. Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation. Molecular carcinogenesis. 2017;56(1):49-61.
  51. Poindexter KM. Cooperative antiproliferative signaling by aspirin and indole-3-carbinol targets microphthalmia-associated transcription factor gene expression and promoter activity in human melanoma cells. Cell biology and toxicology. 2016;32(2):103-19.
  52. Quirit JG, Lavrenov SN, Poindexter K, Xu J, Kyauk C, Durkin KA, et al. Indole-3-carbinol (I3C) analogues are potent small molecule inhibitors of NEDD4-1 ubiquitin ligase activity that disrupt proliferation of human melanoma cells. Biochemical pharmacology. 2017;127:13-27.
  53. Rothman DM, Gao X, George E, Rasmusson T, Bhatia D, Alimov І. Metabolic Enzyme Sulfotransferase 1A1 Is the Trigger for N-Benzyl Indole Carbinol Tumor Growth Supression. Chemistry & biology. 2015;22(9):1228-37.
  54. Song JM. Combinations of indole-3-carbinol and silibinin suppress inflammation-driven mouse lung tumorigenesis by modulating critical cell cycle regulators. Carcinogenesis. 2015;36(6):666-75.
  55. Kim EK, Kim YS, Milner JA, Wang TT. Indole-3-carbinol and 3’,3’-diindolylmethane modulate androgen’s effect on C-C chemokine ligand 2 and monocyte attraction to prostate cancer cells. Cancer Prev Res (Phila). 2013;6(6):519-29.
  56. Wu TY, Saw CLL, Khor TO, Pung D, Boyanapalli SS, Kong ANT. In vivo pharmacodynamics of indole-3-carbinol in the inhibition of prostate cancer in transgenic adenocarcinoma of mouse prostate (TRAMP) mice: involvement of Nrf 2 and cell cycle/apoptosis signaling pathways. Mol Carcinog. 2012;51(10):761-70.
  57. Sarkar FH, Li Y. Indole-3-carbinol and prostate cancer. J Nutr. 2004;134(12):3493-8.
  58. Wang TT, Schoene NW, Milner JA, Kim YS. Broccoli-derived phytochemicals indole-3-carbinol and 3,3’-diindolylmethane exerts concentrationdependent pleiotropic effects on prostate cancer cells: comparison with other cancer preventive phytochemicals. Mol Carcinog. 2012;51(3):244-56.
  59. Busbee PB. Indole-3-carbinol ameliorates murine colitis symptoms through alterations in gut microbial composition and metabolomic pathways, particularly through decreasing disease-associated. Bacteroides acidifaciens species. 2017;1:198-218.
  60. Paliwal P, Chauhan G, Gautam D, Dash D, Patne S, Krishnamurthy S. Indole-3-carbinol improves neurobehavioral symptoms in a cerebral ischemic stroke model. Naunyn-Schmiedeberg’s archives of pharmacology. 2018;391(6):613-25.


Publication of the article:

«Bulletin of problems biology and medicine» Issue 3 (145), 2018 year, 30-38 pages, index UDK 618.14-002+618.14-006.36